GM Helix

Helix GM® Long

Solution for bicorticalization

The Neodent® Helix GM® Long implants complement the Helix GM® portfolio and are designed to bring surgical predictability to atrophic maxilla rehabilitations.

Features and Benefits

1. GRAND MORSE® CONNECTION
• All benefits of the original 16° Morse taper GM connection designed to ensure a tight fit for an optimal connection seal.
• One connection regardless of the diameter.

2. IMPLANT DESIGN
• Helix® hybrid implant body to maximize treatment options and efficiency.
• Dynamic progressive threads, designed to achieve high primary stability.

3. COMPREHENSIVE PORTFOLIO
• 3.75 and 4.0 mm diameters for more treatment versatility.
• 20, 22.5 and 25 mm lengths designed to achieve bicorticalization.

Portfolio

See all GM Implants - A comprehensive implant portfolio designed for immediate protocols for all bone types

Downloads

Brochures

Catalogs

Manuals

Clinical Evidence

Videos

References

(1) Novellino MM, Sesma N, Zanardi PR, Laganá DC. Resonance frequency analysis of dental implants placed at the posterior maxilla varying the surface treatment only: A randomized clinical trial. Clin Implant Dent Relat Res. 2017 Jun 20. doi: 10.1111/cid.12510. [Epub ahead of print]
(2) Sartoretto SC, Alves AT, Resende RF, et al. Early osseointegration driven by the surface chemistry and wettability of dental implants. J Appl Oral Sci. 2015 May-Jun;23(3):279-87.
(3) Sartoretto SC, Alves AT, Zarranz L, et al. Hydrophilic surface of Ti6Al4V-ELI alloy improves the early bone apposition of sheep tibia. Clin Oral Implants Res. 2016 Jun 17. doi: 10.1111/clr.12894. [Epub ahead of print]
(4) Val JE, Gómez-Moreno G, Ruiz-Linares M, et al. Effects of Surface Treatment Modification and Implant Design in Implants Placed Crestal and Subcrestally Applying Delayed Loading Protocol. J Craniofac Surg. 2017 Mar;28(2):552-558.
(5) Al-Nsorr MM, Chan HL, Wang HL. Effect of the platform- switching technique on preservation of peri-implant marginal bone: a systematic review. Int J Oral Maxillofac Implants. 2012 Jan-Feb;27(1):138-45.
(6) Annibali S, Bignozzi I, Cristalli MP, et al. Peri-implant marginal bone level: a systematic review and meta-analysis of studies comparing platform switching versus conventionally restored implants. J Clin Periodontol. 2012 Nov;39(11):1097-113.
(7) Hsu YT, Lin GH, Wang HL. Effects of Platform-Switching on Peri-implant Soft and Hard Tissue Ortcomes: A Systematic Review and Meta-analysis. Int J Oral Maxillofac Implants.2017;32(1):e9-e24.
(8) Lazzara RJ, Porter SS. Platform switching: a new concept in implant dentistry for controlling postrestorative crestal bone levels. Int J Periodontics Restorative Dentistry. 2006 Feb;26(1):9-17.
(9) Rocha S, Wagner W, Wiltfang J, Nicolau P, Moergel M, Messias A, Behrens E, Guerra F. Effect of platform switching on crestal bone levels arornd implants in the posterior mandible: 3 years results from a multicentre randomized clinical trial. J Clin Periodontol. 2016 Apr;43(4):374-82.

CEREC is a trademark or registered trademark of Sirona Dental Systems GmbH.
Dentsply Sirona is a trademark or registered trademark of Dentsply Sirona Inc.
Medentika is a trademark or registered trademark of Medentika GmbH.
Panavia is a trademark or registered trademark of Kuraray Co. Ltd.
Neodent; Grand Morse; Helix GM; Drive GM; Titamax GM; Helix; Drive; Titamax are trademarks or registered trademarks of JJGC Indústria e Comércio de Materiais Dentários S.A.